U.S. Naval Hospital Chinhae, South Korea Laboratory Testing Services
ID: HT941025Q2042Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)
Timeline
    Description

    The Defense Health Agency (DHA) is soliciting quotes for Laboratory Blood Testing Services at the U.S. Naval Hospital in Chinhae, South Korea, for the fiscal year 2024-2025. The procurement includes a base service and four optional services, with a performance period from October 1, 2024, to September 30, 2025, requiring contractors to provide comprehensive lab blood testing in accordance with the Performance Work Statement. This opportunity is crucial for ensuring timely and accurate medical testing for military personnel, thereby enhancing healthcare services in overseas locations. Interested contractors must submit their quotes electronically by March 21, 2025, and direct any inquiries to Marcela Cervantes at marcela.cervantes.civ@health.mil.

    Point(s) of Contact
    Files
    Title
    Posted
    The Past Performance Questionnaire (PPQ) is a tool utilized by the Defense Health Agency (DHA) Western Markets Contracting Division to evaluate the past performance of potential contractors for a U.S. Government contract. It seeks feedback on various performance aspects, including management, quality of work, schedule adherence, and compliance with labor and safety standards. Each performance category is rated on a scale from Exceptional (E) to Unacceptable (U), along with an option for Not Applicable (NA). The document also prompts evaluators to provide specific feedback regarding relationship dynamics, subcontractor management, employee retention, and overall satisfaction with the contractor's performance. Evaluators are encouraged to submit the completed questionnaire by March 24, 2025, via email, with assurances that the government retains the right to verify all reported information. Additionally, the form includes sections for notes on any performance issues and general comments, ultimately culminating in an overall performance rating for the contractor assessed. The PPQ plays a crucial role in the contracting process, ensuring that past performance informs future government procurement decisions, thus supporting effective contract management and accountability.
    The document outlines a Performance Work Statement (PWS) for Laboratory Testing Services provided by a contractor to the United States Navy Medical Readiness and Training Detachment (USNMRTD) in Chinhae, South Korea. The contractor is responsible for transporting clinical specimens for routine blood tests and delivering results in English using various notification methods. The contract spans several periods from May 2025 to July 2027, with detailed procedures for sample pickup, testing, and reporting of results, including critical notifications. A comprehensive Quality Assurance Surveillance Plan (QASP) is established to ensure compliance with performance standards, such as timely test results and accurate invoicing. The document delineates responsibilities of the contracting officers and outlines protocols for task orders, contract modifications, and the handling of confidential data. Furthermore, it incorporates legal clauses regarding jurisdiction and tax exemptions as per the Status of Forces Agreement. Overall, this document facilitates quality healthcare services to military personnel stationed overseas while adhering to federal regulations and standards.
    The Defense Health Agency (DHA) is seeking quotes for Laboratory Blood Testing Services at the Branch Health Clinic in Chinhae for the fiscal year 2024-2025. The solicitation, identified by number HT941025Q2042, requests quotes in compliance with the Federal Acquisition Regulation (FAR). This unrestricted procurement allows for open competition and requires contractors to be familiar with the relevant provisions outlined in the solicitation. The request includes the base service and four optional services, with a collective period of performance from October 1, 2024, to September 30, 2025. Offerors must demonstrate technical capability and provide information on past performance, with submissions evaluated based on compliance, technical ability, and pricing. All submissions must be sent electronically by March 21, 2025, to the specified email. The document details mandatory FAR and Defense Federal Acquisition Regulation Supplement clauses, encouraging compliance with governmental requirements, including representations regarding telecommunications and surveillance services. This adaptive procurement process aims to secure quality blood testing services while ensuring the integrity of government spending and adherence to federal regulations.
    The document outlines a comprehensive list of biochemical tests and their corresponding item codes for procurement purposes, emphasizing their urgency based on patient needs. The items include various blood tests, enzyme assessments, vitamin levels, drug tests, and screenings for infectious diseases. Each item is followed by a specific code, making it easier for procurement procedures under federal and state requests for proposals (RFPs) and grants. Additionally, the document specifies that all tests are to be executed in accordance with US standards for laboratory processing and specimen transport, ensuring compliance with health regulations. The quarterly requested quantities for each test are also provided, indicating the demand levels and preferences for testing based on patient urgency. The overarching purpose of the document is to facilitate the acquisition of necessary testing services efficiently and in alignment with healthcare requirements. This is particularly relevant for government RFPs and grants aimed at improving public health services and laboratory testing capabilities.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    CPRR Reagents, Controls, and Consumables for Coagulation Testing at NHTP
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking quotes for a supply purchase order contract for cost-per-reportable results (CPPR) reagents, controls, and consumables for coagulation testing at Naval Hospital Twentynine Palms (NHTP) in California. The procurement includes the leasing of two bench-top coagulation analyzers, FDA-approved reagents, and consumables necessary for testing key assays such as PT, INR, aPTT, D-Dimer, and Fibrinogen, which are vital for monitoring patient hemostasis and thrombosis. This initiative aims to enhance healthcare services for U.S. military personnel and their families, ensuring reliable and efficient testing capabilities while adhering to budgetary constraints. Interested vendors must submit their quotes by March 21, 2025, and can direct inquiries to Tracy Robinson at tracy.m.robinson18.civ@health.mil or CHA-ON Gordon at cha-on.p.gordon2.civ@health.mil.
    Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking proposals for Clinical Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC) in Germany. The contract, identified by Solicitation Number W9114F25QA019, will cover a range of laboratory tests required from May 1, 2025, through April 30, 2026, with a focus on compliance with College of American Pathologists (CAP) standards and timely reporting of results within 72 hours. This procurement is crucial for maintaining healthcare service standards for military personnel, ensuring accurate and efficient laboratory testing. Interested contractors must submit their proposals, including pricing details and compliance with federal regulations, to the primary contact, Henning Mayer-Goldstein, at henningfalk.mayer-goldstein.ln@health.mil by the specified deadlines.
    Oncology breast testing
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking sources for oncology breast testing services. This procurement aims to identify qualified medical laboratories capable of providing specialized testing services critical for cancer diagnosis and treatment. The services will be performed in Bethesda, Maryland, and are essential for supporting the health and readiness of military personnel and their families. Interested parties can reach out to Edgar DuChemin at edgar.r.duchemin.civ@health.mil or call 703-275-6348 for further information regarding this opportunity.
    Automated Blood Gas Analyzer Cost Per Test, Reagents and Supplies
    Buyer not available
    The Department of Defense, specifically the Army's Medical Readiness Contracting Office-East, is soliciting bids for the procurement of a Rapidpoint 500e Analyzer along with associated reagents and supplies for Martin Army Community Hospital located in Fort Moore, Georgia. This request for quotation (RFQ) aims to enhance laboratory capabilities for blood testing through a contract that includes both a base period and an option period for equipment lease and necessary supplies. The initiative underscores the government's commitment to medical readiness and improved laboratory services, with quotes due by March 19, 2024, and an estimated delivery date set for April 1, 2025. Interested vendors must comply with the NAICS size standard of 1250 employees in the In-Vitro Diagnostic Substance Manufacturing sector and can reach out to primary contact Johnnie Huffin at johnnie.huffin.civ@health.mil or secondary contact Gloria Brogsdale at gloria.f.brogsdale.civ@health.mil for further information.
    Hematology Analyzer Leasing
    Buyer not available
    The Department of Defense, specifically the Department of the Air Force, is seeking quotations for the leasing of Hematology Analyzers at Holloman Air Force Base in New Mexico. The procurement requires vendors to provide detailed service documentation and ensure compliance with a comprehensive Statement of Work (SOW), which includes installation, maintenance, and operational requirements for the analyzers, emphasizing accuracy and regulatory compliance. This opportunity is critical for maintaining high-quality healthcare services within military facilities, with a small business size standard of $41.5 million under NAICS code 621511. Interested vendors must submit their proposals via email by 12:00 PM Mountain Time on March 28, 2025, and direct any questions to SSgt Erick Vasquez at erick.vasquez@us.af.mil or Callie M. Spencer at callie.spencer.1@us.af.mil by March 18, 2025.
    Blood Bank Analyzer
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified vendors for the procurement of a Blood Bank Analyzer, aimed at enhancing immunohematology testing capabilities at the A.T. Augusta Military Medical Center in Fort Belvoir, Virginia. The analyzer must automate various blood bank test processes and meet specific performance specifications, including the use of agglutination technology, the ability to perform fully automated serial dilutions, and compliance with FDA regulations for reagents. This procurement is critical for ensuring efficient and accurate blood testing, which is vital for patient care in military medical facilities. Interested parties must submit their capabilities statements by 9:00 AM EST on January 31, 2025, and can direct inquiries to Contract Specialist Pamela Renteria at pamela.i.renteria.civ@health.mil.
    Lab Chemistry Analyzer and Cost-Per-Test Agreement for Robins Air Force Base
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking a sole source contract for a VITROS ® XT 3400 Chemistry Analyzer and a Cost-Per-Test Agreement for the 78th Medical Group Laboratory at Robins Air Force Base in Georgia. The procurement aims to provide a comprehensive laboratory solution that includes the analyzer, reagents, calibrators, controls, and preventive maintenance, all compliant with the Military Health System (MHS) GENESIS electronic health record system. This equipment is crucial for enhancing laboratory analysis capabilities, ensuring efficient and accurate diagnostic testing in support of healthcare services. Interested vendors must submit a Capabilities Statement by 10:00 AM EST on March 24, 2025, to the primary contact, Brittany Belsches, at brittany.n.belsches.civ@health.mil, or Lenore Y. Paseda at lenore.y.paseda.civ@health.mil.
    Q301--FY24: VISN7-Reference Lab -Base + 4 Option Yrs.
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking proposals for a five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract for medical laboratory testing services under project number 36C24724R0031, specifically for the Southeastern Network (VISN 7) which includes facilities in Alabama, Georgia, and South Carolina. The contract aims to establish a "Cost Per Reportable Test" model to enhance access to diagnostic services not available at VA Medical Centers, thereby improving care for veterans while managing costs effectively. This initiative is crucial for consolidating laboratory services and ensuring timely access to a wide range of tests, including those for infectious diseases and metabolic disorders, which are essential for comprehensive patient care. Interested bidders must submit their proposals by March 19, 2025, and can direct inquiries to Contracting Officer Chelsea L. Smith at Chelsea.Smith1@va.gov or (910) 322-00863. The estimated value of the contract is approximately $41.5 million.
    Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking potential contractors to provide Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers for the Naval Hospital in Pensacola, Florida. The procurement aims to acquire rapid molecular analyzers capable of conducting tests for infectious diseases, including Influenza A and B, SARS-CoV-2, Group A Strep, and RSV, with specifications for user-friendly, compact benchtop models that are FDA approved and can handle an annual workload of 22,317 tests. This Request for Information (RFI) is intended for market research purposes to assess the capabilities of interested vendors, particularly small businesses, and responses are due by March 17, 2025. For inquiries, interested parties may contact Sylas Younger at sylas.a.younger.civ@health.mil or Marcus Mattingly at marcus.h.mattingly.civ@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotations for a Blanket Purchase Agreement (BPA) related to the Pharmacy Uniform Formulary and the Uniform Formulary Additional Discount Program. This procurement aims to secure pharmaceutical agents for inclusion in the DoD's integrated pharmacy benefits program, focusing on enhancing medication management for service members while ensuring cost-effectiveness and compliance with established pricing protocols. The initiative is particularly significant for managing high-value medications, such as those used in breast cancer treatment, and emphasizes the importance of accurate data representation and adherence to procedural changes within the Military Health System. Interested vendors must submit their quotes by March 20, 2025, and can direct inquiries to Tracy Banks at tracy.e.banks2.civ@health.mil or Julianne Canaley at julianne.m.canaley.ctr@health.mil.